The big opportunities in currencies happen at extremes… That's the moment that you want to consider trading them. I don't trade currencies that often. But when these extremes materialize, I get in. We haven't seen many currency extremes lately. But we are about to… The U.S. dollar has gained roughly 25% in three years against the world's major currencies. Said another way, the world's major currencies have lost a heck of a lot of ground against the U.S. dollar – in just three years. Finally, we are approaching extreme levels. We are reaching the point where we will look to get some money outside the U.S. dollar again. But where are the extremes? The United Kingdom and Mexico are the obvious choices. Let's look at the U.K. first…
good stocks to invest: Polo Ralph Lauren Corporation(RL)
Advisors’ Opinion:
- [By Casey Wilson]
Ralph Lauren Corp. (NYSE: RL) just became the latest company to fall victim to the “Retail Ice Age.”
The 50-year-old American icon announced it shuttered its flagship store at Fifth Avenue and 55th Street in New York City on Tuesday (April 4). It will also close 50 other retail locations by the end of the fiscal year.
- [By Ben Levisohn]
Hanesbrands was just one of many retail companies that got shellacked this week. Under Armour (UAA) tumbled 29% after missing earnings forecasts and cutting its guidance, while Deckers Outdoor (DECK) plunged 21% after its earnings missed the Street consensus, and Ralph Lauren (RL) plummeted 13% after its CEO stepped down.
- [By Casey Wilson]
Amazon has been a growing pain in the neck for low-price retailers like Wal-Mart Stores Inc. (NYSE:WMT) for some time, but even high-end specialty stores like Ralph Lauren Corp. (NYSE: RL) have struggled now that Amazon has crept into their sector.
- [By Johanna Bennett]
Times are tough for Ralph Lauren (RL). Profit and sales are fallingat theiconic clothingcompany, and investors who bet on a turnaround havelost their shirts on the stock. Adding to its troubles,CEO StefanLarsson is departingfollowing a creative clash with the companys namesake and founder.
Pessimism, meanwhile, appears to be on the rise.
According to a report by the financial analytics company S3 Partners, short interest in Ralph Lauren has risen since the start of the year, hitting historical levels. And while that short position is expected to keep expanding, bearish sentiments could turn on a dime.
Ihor Dusaniwsky at S3 Partners writes:
RL short interest levels, already at historical highs today, should continue to grow if the recent trend continues, but having made almost 23% in 2016 and 14% in 2017, short sellers may be quick to cover their positions and lock in profits if RLs stock price turns against them.
Short interest in Ralph Lauren fell in 2016 as the stock price fella nd shorts covered positions, netting a return of 22.6%. So far this year, however, the short position as increased $226 million, or 38% to $815 million as of this morning, according to the S3 report.
Its a profitable day for those short sellers. Todays 11% decline Ralph Laurens stock price on an $815 million short position has added $90 million to the short sellers collective bottom line.
Ralph Lauren is down 11.5% in recent market actions to $77.26 a after earlier falling as low as $76.86 a share. Thats the lowest price for the stock since 2010.
- [By WWW.THESTREET.COM]
The sidewalks outside stores like Armani, Dolce & Gabanna, Ralph Lauren (RL) , Gap (GPS) , Prada, Abercrombie & Fitch (AF) , Microsoft (MSFT) and Harry Winston are now lined with metal barricades. The strip commands some of the highest retail rents in the world, with the average annual rent being $3500 per square foot.
good stocks to invest: Codexis, Inc.(CDXS)
Advisors’ Opinion:
- [By Jim Robertson]
On Tuesday, our Under the Radar Moversnewsletter suggested taking a long/bullish position in small cap biocatalysts developer Codexis, Inc (NASDAQ: CDXS):
- [By Maxx Chatsko]
While companies with lower-priced shares are often riskier than those with higher prices, some companies trading under $5 per share have intriguing potential. Investors searching for overlooked growth opportunities should consider industrial biotech BioAmber (NYSE:BIOA), pharmaceutical services company Codexis (NASDAQ:CDXS), and one-trick-pony biopharma Keryx Biopharmaceuticals (NASDAQ:KERX).
good stocks to invest: ManpowerGroup(MAN)
Advisors’ Opinion:
- [By Lisa Levin] Related TRST Earnings Scheduled For October 21, 2016 Major Accounting Changes Are Coming To The Financial Industry Related MORN One Of The World's Most Powerful Women, Fidelity Personal Investing President Kathleen Murphy, To Tell Her Story At The Benzinga Global Fintech Awards The 2017 Benzinga Global Fintech Awards Will Include An 'Unprecedented Group' Of Judges Morningstar Packs Conference Lineup For Financial Advisors (Investor’s Business Daily) Companies Reporting Before The Bell Rockwell Collins, Inc. (NYSE: COL) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.33 billion. General Electric Company (NYSE: GE) is expected to report quarterly earnings at $0.17 per share on revenue of $26.46 billion. Honeywell International Inc. (NYSE: HON) is estimated to report quarterly earnings at $1.60 per share on revenue of $9.32 billion. Interpublic Group of Companies Inc (NYSE: IPG) is expected to report quarterly earnings at $0.03 per share on revenue of $1.76 billion. Schlumberger Limited. (NYSE: SLB) is estimated to report quarterly earnings at $0.26 per share on revenue of $7.02 billion. SunTrust Banks, Inc. (NYSE: STI) is expected to report quarterly earnings at $0.83 per share on revenue of $2.21 billion. ManpowerGroup Inc. (NYSE: MAN) is projected to report quarterly earnings at $1.11 per share on revenue of $4.68 billion. Kansas City Southern (NYSE: KSU) is estimated to report quarterly earnings at $1.15 per share on revenue of $593.82 million. Stanley Black & Decker, Inc. (NYSE: SWK) is projected to report quarterly earnings at $1.19 per share on revenue of $2.74 billion. WABCO Holdings Inc. (NYSE: WBC) is estimated to report quarterly earnings at $1.44 per share on revenue of $721.89 million.
- [By Bryan Murphy]
Look out ManpowerGroup Inc. (NYSE:MAN). And Robert Half International Inc. (NYSE:RHI)? You may want to look over your shoulder as well. A young-and-hungry staffing solutions competitor named Staffing 360 Solutions Inc (NASDAQ:STAF) is coming on strong, and just proved it again today. Some of its preliminary fiscal Q2 numbers were reported today, and they extend what’s become a long-term growth streak.
The definition of a roll-up isn’t a hard and fast one, though even the broad brush strokes paint a pretty clear picture. Investopedia defines a roll-up (also known as a “roll up” or a “rollup”) a merger that occurs when investors (often private equity firms) buy up companies in the same market and merge them together. Roll-ups combine multiple small companies into something bigger and better to be able to enjoy economies of scale. Private equity firms use roll-ups to rationalize competition in crowded and/or fragmented markets and to combine companies with complementary capabilities into a full-service business.
It’s also the kind of strategy Staffing 360 Solutions is executing, with great success. For the fiscal quarter ending in November, Staffing 360 Solutions has pre-reported revenue of $47 million, and a gross profit of $8.1 million. Those figures are up 14% and 8%, respectively, year-over-year.
- [By Bryan Murphy]
Staffing agencies like Robert Half International Inc. (NYSE:RHI) and ManpowerGroup Inc. (NYSE:MAN) may want to look over their shoulder. Though both are bigger and more established, their size and the waning need for physical, human workers in an increasingly-digital and roboticized world ultimately works against both organizations. That paradigm shift doesn’t matter much to a young, up-coming-staffing agency called Staffing 360 Solutions Inc (NASDAQ:STAF) though. Indeed, the trend of computer-based everything leaves Staffing 360 Solutions in the proverbial cat-bird’s seat. Its fiscal Q2 numbers verify the company is in the right place at the right time.
Those numbers? Revenue of $47.1 million was up 14%, and gross profits of $8.1 million were higher by 8.4% on a year-over-year basis. Moreover, the net loss of $1.5 million was a marked improvement on the year-ago loss of $3.5 million, and the EBITDA of $1.4 million was about the same. Operating expenses fell from 22% of revenue a year earlier to only 17% last quarter, with more such progress on the way.
Perhaps most important, Staffing 360 Solutions saw organic growth of 7%, meaning the top line bumped up by that much not because of acquisitions, but because it’s existing divisions expanded their client base and billings by 7%.
And last quarter’s progress has been the norm for several quarters now.
While STAF is proving outpacing the growth from bigger names like ManpowerGroup and Robert Half International, it can’t come as a complete surprise. Staffing 360 Solutions is focused on the IT sliver of the staffing industry, connecting companies with the technology-skilled programmers, cybersecurity specialists, and computer networking personnel modern organizations increasingly need.
There are several data nuggets that point in the same direction, but perhaps none as telling as a recent conclusion from technology research outfit IDC speaks volumes. IDC believes that by the
good stocks to invest: NGL ENERGY PARTNERS LP(NGL)
Advisors’ Opinion:
- [By Lisa Levin]
Shares of NGL Energy Partners LP (NYSE: NGL) were down around 24 percent to $16.40. NGL Energy Partners declared a quarterly distribution of $0.39 per unit and revised its fiscal year 2017 and fiscal year 2018 outlook.
- [By Lisa Levin]
On Friday, the energy sector proved to be a source of strength for the market. Leading the sector was strength from NGL Energy Partners LP (NYSE: NGL) and Legacy Reserves LP (NASDAQ: LGCY).
good stocks to invest: Chimerix, Inc.(CMRX)
Advisors’ Opinion:
- [By WWW.MONEYSHOW.COM]
The lead product candidate from Chimerix (CMRX) is brincidofovir (CMX001), a nucleotide analog.
The drug is in Phase III clinical trials for the prevention of cytomegalovirus (CMV) in allogeneic hematopoietic cell transplant (HCT) recipients and in kidney transplant recipients, as well as to treat adenovirus infection in allogeneic HCT patients.